Drug intelligence / Profile preview

MC001

Development stage
Discontinued
Lead developer
StemCyte
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intrathecal, Implant
01

Overview

**MC001** is an investigational allogeneic regenerative cell therapy developed by StemCyte for chronic, stable, complete spinal cord injury. The product comprises human leukocyte antigen matched umbilical cord blood mononuclear cells, including monocytes and CD34-positive and CD133-positive cell populations. It is surgically transplanted into dorsal root entry zones above and below the spinal-cord injury site and is followed by intensive locomotor rehabilitation. MC001 is intended to support neuronal repair and functional recovery through the combined regenerative, neuroprotective, and immunomodulatory activities of its heterogeneous cord-blood cell population. A StemCyte-sponsored Phase II study in chronic complete spinal cord injury, NCT03979742, was terminated.

Other names
allogeneic HLA-matched umbilical cord blood mononuclear cellsHLA-matched umbilical cord blood mononuclear cellsUCBMNC

Beyond the preview

Go deeper on MC001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MC001.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call